Qualcomm Life Fund [QLF], a healthcare fund run by US-based semiconductor company Qualcomm’s corporate venturing unit, has sealed its eighth deal.

Qualcomm Life Fund, managed by Qualcomm Ventures, has backed GoBalto, a US-based clinical study startup, as part of a $12m round. The series B round was led by EDBI, the investment unit of Singapore’s Economic Development Board.

GoBalto’s flagship product is Tracker, – a clinical research tool which allows clinical trial sponsors and research organizations to study patients.


Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?